Large-scale testing (Phase 3)Study completedNCT01235962
What this trial is testing
Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Who this might be right for
Renal Cell Carcinoma (RCC)Cancer
Novartis Pharmaceuticals 1,538